The Consumer Tissue Private Label Europe business remains a part of the Essity Group and thereby the strategic review of the division, which began on April 26, 2023, is concluded. 

Essity continuously evaluates its various businesses to increase long-term value creation. In the strategic review of Consumer Tissue Private Label Europe it was concluded that the business as a result of the implemented divisionalization, is a competitive and value-creating part of Essity.

Net sales for the Consumer Tissue Private Label Europe business amounted to approximately SEK 9.8 billion in 2022. The business encompasses seven production facilities in Belgium, France, Germany and Italy with approximately 1900 employees.